When two pandemics meet: Why is obesity associated with increased COVID-19 mortality?
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
A growing body of evidence indicates that obesity is strongly and independently associated with adverse outcomes of COVID-19 including death. By combining emerging knowledge of the pathological processes involved in COVID-19 with insights into the mechanisms underlying the adverse health consequences of obesity, we present some hypotheses regarding the deleterious impact of obesity on the course of COVID-19. These hypotheses are testable and could guide therapeutic and preventive interventions. As obesity is now almost ubiquitous and no vaccine for COVID-19 is currently available, even a modest reduction in the impact of obesity on mortality and morbidity from this viral infection could have profound consequences for public health.
Description
Keywords
Journal Title
Med cell press
Conference Name
Journal ISSN
2666-6359
2666-6340
2666-6340
Volume Title
1
Publisher
Elsevier
Publisher DOI
Rights and licensing
Except where otherwised noted, this item's license is described as All rights reserved
Sponsorship
Cambridge University Hospitals NHS Foundation Trust (CUH) (146281)
MRC (Unknown)
Wellcome Trust (208363/Z/17/Z)
Wellcome Trust (214274/Z/18/Z)
Wellcome Trust Ltd (100574/B/12/Z)
Medical Research Council (MC_UU_12012/2)
MRC (MC_UU_00014/1)
Wellcome Trust (095515/Z/11/Z)
Medical Research Council (MC_PC_12012)
MRC (Unknown)
Wellcome Trust (208363/Z/17/Z)
Wellcome Trust (214274/Z/18/Z)
Wellcome Trust Ltd (100574/B/12/Z)
Medical Research Council (MC_UU_12012/2)
MRC (MC_UU_00014/1)
Wellcome Trust (095515/Z/11/Z)
Medical Research Council (MC_PC_12012)
S.M.L. is supported by an academic clinical fellowship from the National Institute for Health Research (NIHR). S.O. is supported by the Wellcome Trust (WT 095515/Z/11/Z), the Medical Research Council (MRC) Metabolic Disease Unit (MC_UU_00014/1), and the NIHR Cambridge Biomedical Research Centre and NIHR Rare Disease Translational Research Collaboration
